176 related articles for article (PubMed ID: 19032125)
1. Association between adherence with fixed dose combination fluticasone propionate/salmeterol on asthma outcomes and costs*.
Delea TE; Stanford RH; Hagiwara M; Stempel DA
Curr Med Res Opin; 2008 Dec; 24(12):3435-42. PubMed ID: 19032125
[TBL] [Abstract][Full Text] [Related]
2. Healthcare use and costs in patients with chronic bronchitis initiating maintenance therapy with fluticasone/salmeterol vs other inhaled maintenance therapies.
Delea TE; Hagiwara M; Dalal AA; Stanford RH; Blanchette CM
Curr Med Res Opin; 2009 Jan; 25(1):1-13. PubMed ID: 19210134
[TBL] [Abstract][Full Text] [Related]
3. Effects of fluticasone propionate/salmeterol combination on asthma-related health care resource utilization and costs and adherence in children and adults with asthma.
Delea TE; Hagiwara M; Stanford RH; Stempel DA
Clin Ther; 2008 Mar; 30(3):560-71. PubMed ID: 18405796
[TBL] [Abstract][Full Text] [Related]
4. Health-care utilization and costs with fluticasone propionate and fluticasone propionate/salmeterol in asthma patients at risk for exacerbations.
Hagiwara M; Delea TE; Stanford RH
Allergy Asthma Proc; 2014; 35(1):54-62. PubMed ID: 24433597
[TBL] [Abstract][Full Text] [Related]
5. Risk of asthma exacerbation, asthma-related health care utilization and costs, and adherence to controller therapy in patients with asthma receiving fluticasone propionate/salmeterol inhalation powder 100 μg/50 μg versus mometasone furoate inhalation powder.
Hagiwara M; Delea TE; Stanford RH
J Asthma; 2013 Apr; 50(3):287-95. PubMed ID: 23305687
[TBL] [Abstract][Full Text] [Related]
6. Comparative cost-effectiveness of a fluticasone-propionate/salmeterol combination versus anticholinergics as initial maintenance therapy for chronic obstructive pulmonary disease.
Dalal AA; Roberts MH; Petersen HV; Blanchette CM; Mapel DW
Int J Chron Obstruct Pulmon Dis; 2010 Dec; 6():13-22. PubMed ID: 21311689
[TBL] [Abstract][Full Text] [Related]
7. Risk of hospitalizations/emergency department visits and treatment costs associated with initial maintenance therapy using fluticasone propionate 500 microg/salmeterol 50 microg compared with ipratropium for chronic obstructive pulmonary disease in older adults.
Blanchette CM; Akazawa M; Dalal A; Simoni-Wastila L
Am J Geriatr Pharmacother; 2008 Aug; 6(3):138-46. PubMed ID: 18775388
[TBL] [Abstract][Full Text] [Related]
8. Stepping down to fluticasone propionate or a lower dose of fluticasone propionate/salmeterol combination in asthma patients recently initiating combination therapy.
Hagiwara M; Delea TE; Stanford RH; Stempel DA
Allergy Asthma Proc; 2010; 31(3):203-10. PubMed ID: 20534183
[TBL] [Abstract][Full Text] [Related]
9. The effect of fixed combination of fluticasone and salmeterol on asthma drug utilization, asthma drug cost, and episodes of asthma exacerbations.
Brixner DI; Lenhart G; Young DC; Samuelson WM
Curr Med Res Opin; 2007 Nov; 23(11):2887-95. PubMed ID: 17922979
[TBL] [Abstract][Full Text] [Related]
10. Comparative effectiveness of budesonide-formoterol combination and fluticasone-salmeterol combination for asthma management: a United States retrospective database analysis.
Tunceli O; Williams SA; Kern DM; Elhefni H; Pethick N; Wessman C; Zhou S; Trudo F
J Allergy Clin Immunol Pract; 2014; 2(6):719-26. PubMed ID: 25439363
[TBL] [Abstract][Full Text] [Related]
11. Resource utilization with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapies in children with asthma.
Stempel DA; Riedel AA; Carranza Rosenzweig JR
Curr Med Res Opin; 2006 Mar; 22(3):463-70. PubMed ID: 16574030
[TBL] [Abstract][Full Text] [Related]
12. Comparative effectiveness of budesonide/formoterol and fluticasone/salmeterol for COPD management.
Roberts M; Mapel D; Petersen H; Blanchette C; Ramachandran S
J Med Econ; 2011; 14(6):769-76. PubMed ID: 21942463
[TBL] [Abstract][Full Text] [Related]
13. An observational study of fixed dose combination fluticasone propionate/salmeterol or fluticasone propionate alone on asthma-related outcomes .
Stanford RH; Fuhlbrigge A; Riedel A; Rey GG; Stempel DA
Curr Med Res Opin; 2008 Nov; 24(11):3141-8. PubMed ID: 18838055
[TBL] [Abstract][Full Text] [Related]
14. Impact of adherence to treatment with fluticasone propionate/salmeterol in asthma patients.
Ismaila A; Corriveau D; Vaillancourt J; Parsons D; Stanford R; Su Z; Sampalis JS
Curr Med Res Opin; 2014 Jul; 30(7):1417-25. PubMed ID: 24666139
[TBL] [Abstract][Full Text] [Related]
15. Economic assessment of initial maintenance therapy for chronic obstructive pulmonary disease.
Akazawa M; Hayflinger DC; Stanford RH; Blanchette CM
Am J Manag Care; 2008 Jul; 14(7):438-48. PubMed ID: 18611095
[TBL] [Abstract][Full Text] [Related]
16. Impact of adherence to treatment with tiotropium and fluticasone propionate/salmeterol in chronic obstructive pulmonary diseases patients.
Ismaila A; Corriveau D; Vaillancourt J; Parsons D; Dalal A; Su Z; Sampalis JS
Curr Med Res Opin; 2014 Jul; 30(7):1427-36. PubMed ID: 24666181
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
Nathan RA; Rooklin A; Schoaf L; Scott C; Ellsworth A; House K; Dorinsky P
Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
[TBL] [Abstract][Full Text] [Related]
18. Adding salmeterol to fluticasone propionate or increasing the dose of fluticasone propionate in patients with asthma.
Delea TE; Hagiwara M; Stempel DA; Stanford RH
Allergy Asthma Proc; 2010; 31(3):211-8. PubMed ID: 20615321
[TBL] [Abstract][Full Text] [Related]
19. Long-term use of fluticasone propionate/salmeterol fixed-dose combination and incidence of nonvertebral fractures among patients with COPD in the UK General Practice Research Database.
Miller DP; Watkins SE; Sampson T; Davis KJ
Phys Sportsmed; 2010 Dec; 38(4):19-27. PubMed ID: 21150138
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of combination fluticasone propionate-salmeterol 250/50 microg versus salmeterol in severe COPD patients.
Dalal AA; St Charles M; Petersen HV; Roberts MH; Blanchette CM; Manavi-Zieverink K
Int J Chron Obstruct Pulmon Dis; 2010 Aug; 5():179-87. PubMed ID: 20714371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]